Table 6.
The relationship between serum 25‐hydroxyvitamin D levels and metabolic syndrome based on age categories
| Entire populations | Men | Women | ||||
|---|---|---|---|---|---|---|
| <65 years | >65 years | <65 years | >65 years | <65 years | >65 years | |
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| Unadjusted | 0.99 (0.97–1.01) | 0.97 (0.94–1.00)* | 0.97 (0.94–1.00)* | 0.96 (0.92–1.00)* | 1.00 (0.97–1.02) | 0.98 (0.93–1.05) |
| Adjusted | 0.98 (0.95–1.00) | 0.96 (0.91–1.01) | 0.96 (0.92–1.00)* | 0.97 (0.90–1.04) | 0.99 (0.96–1.03) | 0.96 (0.88–1.06) |
*P < 0.05. 25‐(OH)D, 25‐hydroxyvitamin D; CI, confidence interval; OR, odds ratio.